Evidence map›Paper›PMID 29971594›Full record

ArticleInternational archives of occupational and environmental health2018

Genetic modifiers of radon-induced lung cancer risk: a genome-wide interaction study in former uranium miners.

Albert Rosenberger, Rayjean J Hung, David C Christiani, Neil E Caporaso, Geoffrey Liu, Stig E Bojesen, Loic Le Marchand, Ch A Haiman, Demetrios Albanes, Melinda C Aldrich and 29 more

Open access · greenAbstract read
In one paragraph

Article in International archives of occupational and environmental health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Mapping the Way to Good Health: The Interdisciplinary Challenges of Geographers in Medical Research.International journal of environmental research and public health · 2022
    Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Impact of Gene-Environment Interactions on Cancer Development.International journal of environmental research and public health · 2020
    Review
  13. Radiation-related health hazards to uranium miners.Environmental science and pollution research international · 2020
    Review
  14. Radon Biomonitoring and microRNA in Lung Cancer.International journal of molecular sciences · 2020
    Review
  15. Radiation Protection of Polydatin Against Radon Exposure Injury of Epithelial Cells and Mice.Dose-response : a publication of International Hormesis Society
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

39 authors at 20 institutions in 12 countries.

Albert RosenbergerDepartment of Genetic Epidemiology, University Medical Center, Georg August University Göttingen, Humboldtallee 32, 37073, Göttingen, Germany. arosenb@gwdg.de.ORCID http://orcid.org/0000-0001-7848-1332
Rayjean J HungLunenfeld-Tanenbaum Research Institute, Sinai Health System, University of Toronto, Toronto, ON, Canada.
David C ChristianiDepartment of Environmental Health, Harvard T.H. Chan School of Public Health and Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA.
Neil E CaporasoDivision of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health, Bethesda, MD, USA.
Geoffrey LiuLunenfeld-Tanenbaum Research Institute, Sinai Health System, University of Toronto, Toronto, ON, Canada.
Stig E BojesenDepartment of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Copenhagen, Denmark.
Loic Le MarchandEpidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA.
Ch A HaimanDepartment of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA.
Demetrios AlbanesDivision of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health, Bethesda, MD, USA.
Melinda C AldrichDivision of Epidemiology, Department of Thoracic Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.
Adonina TardonFaculty of Medicine, University of Oviedo and CIBERESP, Oviedo, Spain.
G Fernández-TardónFaculty of Medicine, University of Oviedo and CIBERESP, Oviedo, Spain.
Gad RennertClalit National Cancer Control Center at Carmel Medical Center and Technion Faculty of Medicine, Haifa, Israel.
John K FieldInstitute of Translational Medicine, University of Liverpool, Liverpool, UK.
B KiemeneyDepartments of Health Evidence and Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
Philip LazarusDepartment of Pharmaceutical Sciences, College of Pharmacy, Washington State University, Spokane, WA, USA.
Aage HaugenNational Institute of Occupational Health, Oslo, Norway.
Shanbeh ZienolddinyNational Institute of Occupational Health, Oslo, Norway.
Stephen LamBritish Columbia Cancer Agency, Vancouver, BC, Canada.
Matthew B SchabathDepartment of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Angeline S AndrewDepartment of Epidemiology, Geisel School of Medicine, Hanover, NH, USA.
Hans BrunnsstömLaboratory Medicine Region Skåne, Department of Clinical Sciences and Pathology, Lund University, Lund, Sweden.
Gary E GoodmanSwedish Medical Group, Seattle, WA, USA.
Jennifer A DohertyDepartment of Epidemiology, Geisel School of Medicine, Hanover, NH, USA.
Chu ChenProgram in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
M Dawn TeareSchool of Health and Related Research, University of Sheffield, Sheffield, UK.
H-Erich WichmannInstitute of Epidemiology II, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany.
Judith ManzInstitute of Epidemiology II, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany.
Angela RischThoraxklinik at University Hospital Heidelberg, Heidelberg, Germany.
Thomas R MuleyThoraxklinik at University Hospital Heidelberg, Heidelberg, Germany.
Mikael JohanssonDepartment of Radiation Sciences, Umeå University, Umeå, Sweden.
Paul BrennanInternational Agency for Research on Cancer, World Health Organization, Lyon, France.
Maria Teresa LandiDivision of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health, Bethesda, MD, USA.
Christopher I AmosBiomedical Data Science, Geisel School of Medicine at Dartmouth, Hanover, NH, USA.
Beate PeschInstitute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany.
Georg JohnenInstitute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany.
Thomas BrüningInstitute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany.
Heike BickeböllerDepartment of Genetic Epidemiology, University Medical Center, Georg August University Göttingen, Humboldtallee 32, 37073, Göttingen, Germany.
Maria GomolkaUnit Biological Radiation Effects, Biological Dosimetry, Department of Radiation Protection and Health, Federal Office for Radiation Protection, BfS, Neuherberg, Germany.
Dartmouth College · USInstitute for Prevention and Occupational Medicine · DENational Institutes of Health · USHelmholtz Zentrum München · DENational Institute of Occupational Health · NOUniversidad de Oviedo · ESUniversity of Göttingen · DEUniversity of Toronto · CABC Cancer Agency · CACarmel Medical Center · ILCentre international de recherche sur le cancer · FRFederal Office for Radiation Protection · DEFred Hutch Cancer Center · USHarvard University · USHeidelberg University · DELund University · SEMoffitt Cancer Center · USRadboud University Nijmegen · NLSwedish Medical Center · USUmeå University · SE

Funding

TRANSLATIONAL RESEARCHP30CA076292 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI KENNETH Lynn WRIGHT · 1998 to 2026
$93.5M
The Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4M
The HSPH Education and Research Center of Occupational Safety and HealthT42OH008416 · OH · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI CHRISTIANI, DAVID C · 2005 to 2025
$30.5M
Translating Molecular and Clinical Data to Population Lung Cancer Risk AssessmentU19CA203654 · NCI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Christopher I. Amos, Rayjean J. Hung · 2017 to 2026
$23.7M
Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) StudyZIACP010195 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI ALBANES, DEMETRIUS · 2009 to 2025
$22.5M
THE ROLE OF CAL IN CIF-MEDIATED DEGRADATION OF CFTRP20RR018787 · NCRR · DARTMOUTH COLLEGE · PI STANTON, BRUCE A. · 2003 to 2011
$21.9M
Translational studies of Hsp90 inhibitors in NSCLCP50CA090578 · NCI · DANA-FARBER CANCER INST · PI JOHNSON, BRUCE D · 2008 to 2012
$11.4M
SPORE in Lung CancerP50CA119997 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI GABRILOVICH, DMITRY I · 2008 to 2012
$11.0M
Statistical Methods for Analysis of Massive Genetic and Genomic Data in Cancer ResearchR35CA197449 · NCI · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI XIHONG LIN · 2015 to 2026
$10.9M
Transdisciplinary Research in Cancer of the Lung (TRICL)U19CA148127 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI AMOS, CHRISTOPHER I., LE MARCHAND, LOIC · 2010 to 2014
$10.9M
Epidemiologic Architecture for Genes Linked to Environment (EAGLE)U01HG004798 · NHGRI · VANDERBILT UNIVERSITY · PI CRAWFORD, DANA C · 2008 to 2013
$8.8M
UDP GLUCURONOSYLTRANSFERASES, DETOXIFICATION OF NNKP01CA068384 · NCI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI LAZARUS, PHILIP · 1995 to 2005
$8.5M
NCATS NIH HHS UL1 TR000445NCI NIH HHS K07 CA172294NCI NIH HHS P01 CA068384NCI NIH HHS P20 CA090578NCI NIH HHS P30 CA076292NCI NIH HHS P50 CA090578NCI NIH HHS P50 CA119997NCI NIH HHS R01 CA074386NCI NIH HHS R01 CA092824NCI NIH HHS R01 CA111703NCI NIH HHS R01 CA151989NCI NIH HHS R35 CA197449NCI NIH HHS U01 CA167462NCI NIH HHS U19 CA148127NCI NIH HHS U19 CA203654NCI NIH HHS UM1 CA167462NCRR NIH HHS P20 RR018787NCRR NIH HHS S10 RR025141NHGRI NIH HHS U01 HG004798NIDCR NIH HHS R01 DE013158NIOSH CDC HHS T42 OH008416World Health Organization 001
6 · The paper itself

Abstract

purposeRadon is a risk factor for lung cancer and uranium miners are more exposed than the general population. A genome-wide interaction analysis was carried out to identify genomic loci, genes or gene sets that modify the susceptibility to lung cancer given occupational exposure to the radioactive gas radon.

methodsSamples from 28 studies provided by the International Lung Cancer Consortium were pooled with samples of former uranium miners collected by the German Federal Office of Radiation Protection. In total, 15,077 cases and 13,522 controls, all of European ancestries, comprising 463 uranium miners were compared. The DNA of all participants was genotyped with the OncoArray. We fitted single-marker and in multi-marker models and performed an exploratory gene-set analysis to detect cumulative enrichment of significance in sets of genes.

resultsWe discovered a genome-wide significant interaction of the marker rs12440014 within the gene CHRNB4 (OR = 0.26, 95% CI 0.11-0.60, p = 0.0386 corrected for multiple testing). At least suggestive significant interaction of linkage disequilibrium blocks was observed at the chromosomal regions 18q21.23 (p = 1.2 × 10

conclusionThe well-established association of the genomic region 15q25 to lung cancer might be influenced by exposure to radon among uranium miners. Furthermore, lung cancer susceptibility is related to the functional capability of DNA damage signaling via ubiquitination processes and repair of radiation-induced double-strand breaks by the single-strand annealing mechanism.

Indexed as

Carcinogens, EnvironmentalCase-Control StudiesDNA DamageFemaleGenetic MarkersGenetic Predisposition to DiseaseGenome-Wide Association StudyGenotypeHumansLinkage DisequilibriumLung NeoplasmsMaleMiddle AgedMiningNeoplasms, Radiation-InducedNerve Tissue ProteinsCarcinogens, EnvironmentalCHRNB4 protein, humanGenetic MarkersNerve Tissue ProteinsRadonReceptors, NicotinicUraniumDNA repairGene–environment interactionGWASOccupational exposureRadon progeny

Identifiers

PMID29971594
PMCPMC6375683
OpenAlexW2810252046

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.